Top Markets
Coin of the day
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

RVPHW
Rang in Aktien #39800
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical... Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.
Aktienkurs
$0.003
Zuletzt synchronisiert: 2025-12-12
Marktkapitalisierung
$343.91K
Veränderung (1 Tag)
-16.67%
Veränderung (1 Jahr)
-90.23%
Land
US
Handel Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kategorie

Preis RVPHW mit Marktkapitalisierung von B
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
RVPHW
$0.003
Marktkapitalisierung von Reviva Pharmaceuticals Holdings, Inc.(RVPHW)
Marktkapitalisierung: $343.91K
Mit Stand August 2026 hat Reviva Pharmaceuticals Holdings, Inc. eine Marktkapitalisierung von $343.91K. Das macht Reviva Pharmaceuticals Holdings, Inc. laut unseren Daten zum 39800th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Reviva Pharmaceuticals Holdings, Inc. von 2018 bis 2026
RVPHW im Vergleich zu den Top 5 der beliebtesten stocks
Preis für RVPHW Vermögenswert B Marktkapitalisierung von B Ergebnisse
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
$47,711.80 $343.91K
$5.470T +1,590,393,280.26%
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
$38,967.10 $343.91K
$4.467T +1,298,903,163.71%
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
$36,413.95 $343.91K
$4.174T +1,213,798,343.90%
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
$32,276.47 $343.91K
$3.700T +1,075,882,122.29%
Reviva Pharmaceuticals Holdings, Inc. Reviva Pharmaceuticals Holdings, Inc.
$24,898.97 $343.91K
$2.854T +829,965,414.19%